These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16766813)

  • 41. Canada's Laboratory Centre for Disease Control.
    Davis T
    J Can Dent Assoc; 1995 Jul; 61(7):575-8. PubMed ID: 7627884
    [No Abstract]   [Full Text] [Related]  

  • 42. Getting ahead of the curve while shifting the balance of power--a CCDC's view.
    Gelletlie R
    Commun Dis Public Health; 2002 Mar; 5(1):2-3. PubMed ID: 12070971
    [No Abstract]   [Full Text] [Related]  

  • 43. EUVAC-Net: the surveillance network for vaccine-preventable diseases is now hosted by ECDC.
    Derrough T; Navarro Torne A
    Euro Surveill; 2011 Sep; 16(37):. PubMed ID: 21944559
    [No Abstract]   [Full Text] [Related]  

  • 44. DIPNET - establishment of a dedicated surveillance network for diphtheria in Europe.
    Neal S; Efstratiou A
    Euro Surveill; 2007 Dec; 12(12):E9-E10. PubMed ID: 18076863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Third Director of the European Centre for Disease Prevention and Control takes office.
    Eurosurveillance editorial team
    Euro Surveill; 2017 Jun; 22(25):. PubMed ID: 28662765
    [No Abstract]   [Full Text] [Related]  

  • 46. Developing healthy public policy in Nigeria.
    Anya I
    Lancet; 2004 Feb; 363(9408):573-4. PubMed ID: 14975634
    [No Abstract]   [Full Text] [Related]  

  • 47. Bichat clinical guidelines for bioterrorist agents.
    Bossi P; Van Loock F; Tegnell A; Gouvras G;
    Euro Surveill; 2004 Dec; 9(12):E1-2. PubMed ID: 15677849
    [No Abstract]   [Full Text] [Related]  

  • 48. The governance of disease control in Europe.
    Fox DM
    J Health Polit Policy Law; 2012 Dec; 37(6):1121-32. PubMed ID: 22899833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Setting priorities: the Canadian experience in communicable disease surveillance.
    Carter AO;
    MMWR Morb Mortal Wkly Rep; 1992 Dec; 41 Suppl():79-84. PubMed ID: 1344268
    [No Abstract]   [Full Text] [Related]  

  • 50. A European biotechnology transfer platform?
    Suojanen C
    N Biotechnol; 2009 Apr; 25(4):167-8. PubMed ID: 19429530
    [No Abstract]   [Full Text] [Related]  

  • 51. The prevention of leprosy related disability as an integral component of the government health delivery programme in Myanmar.
    Cross H
    Lepr Rev; 2012 Jun; 83(2):205-17. PubMed ID: 22997697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Strategies for recognition, prevention and control of antimicrobial resistances in Germany - a draft from the Federal German Ministry of Health].
    Barger A; Schaade L; Krause G; Kramer M
    Gesundheitswesen; 2008 Nov; 70(11):631-5. PubMed ID: 19039718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perspectives for a European Centre for Disease Prevention and Control.
    Kokki M; Haigh R
    Euro Surveill; 2004 Oct; 9(10):3-4. PubMed ID: 15507730
    [No Abstract]   [Full Text] [Related]  

  • 54. [Healthcare policy at the EU level: strategies for action of the European Commission exemplified by patient safety].
    Barth S; Godschalk B; Jonitz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Jan; 58(1):10-5. PubMed ID: 25385039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pan-EU Biobanks.
    Nasto B
    Nat Biotechnol; 2008 Jul; 26(7):725. PubMed ID: 18612283
    [No Abstract]   [Full Text] [Related]  

  • 56. Ensuring prudent use of antimicrobials in human medicine: forceful action needed in Europe.
    Euro Surveill; 2006 Jan; 11(1):E060112.3. PubMed ID: 16801704
    [No Abstract]   [Full Text] [Related]  

  • 57. Differences and commonalities of national field epidemiology training programmes in Europe.
    Krause G; Aavitsland P; Alpers K; Barrasa A; Bremer V; Helynck B; Perra A
    Euro Surveill; 2009 Oct; 14(43):. PubMed ID: 19883560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Communicable and vaccine-preventable conditions under surveillance by the APSU: 2004 update.
    Zurynski Y; Cronin P; Elliott EJ
    Commun Dis Intell Q Rep; 2005; 29(4):407-11. PubMed ID: 16465933
    [No Abstract]   [Full Text] [Related]  

  • 59. Visions for the next five years: ECDC as a sustainable and service-oriented organisation.
    Sprenger M
    Euro Surveill; 2010 May; 15(19):pii/19564. PubMed ID: 20483110
    [No Abstract]   [Full Text] [Related]  

  • 60. The early warning and response system for communicable diseases in the EU: an overview from 1999 to 2005.
    Guglielmetti P; Coulombier D; Thinus G; Van Loock F; Schreck S
    Euro Surveill; 2006; 11(12):215-20. PubMed ID: 17370969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.